Hospital
Jamaica Hospital
Jamaica Hospital was paid $27.88M by Medicaid between Jan 2018 and Nov 2024, across 246 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 17% of everything it billed.
33Billing provider infoJAMAICA HOSPITAL
JAMAICA, NY 11418
JAMAICA, NY 11418
33aNPI1780624049assigned 06/07/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$27.88M
24GClaims472,044
24DCodes billed246
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#46 of 231
Median peer was paid$561K
This provider vs. median50×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,975 | $72K | |
| 2019 | 21,816 | $1.05M | |
| 2020 | 70,440 | $3.58M | |
| 2021 | 98,952 | $5.15M | |
| 2022 | 95,916 | $7.88M | |
| 2023 | 103,899 | $6.02M | |
| 2024incomplete | 79,046 | $4.12M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 29,211 | 25,290 | $4.83M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 19,167 | 17,873 | $3.07M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.7% | 8,324 | 7,867 | $1.86M |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 4.8% | 1,394 | 1,261 | $1.33M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.5% | 8,172 | 7,510 | $1.26M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.0% | 6,866 | 6,391 | $1.13M |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.9% | 3,730 | 3,588 | $1.08M |
| 36415 | Collection of venous blood by venipuncture | 3.6% | 26,256 | 23,235 | $1.01M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.9% | 5,369 | 5,190 | $809K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 2.6% | 4,846 | 1,933 | $724K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.5% | 3,557 | 3,441 | $694K |
| 80053 | Comprehensive metabolic panel | 2.4% | 12,348 | 11,593 | $671K |
234 more codes
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.3% | 3,758 | $630K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.9% | 3,401 | $531K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1.5% | 717 | $426K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.5% | 2,466 | $405K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.3% | 8,449 | $373K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.3% | 2,936 | $363K |
| 92551 | 1.2% | 3,563 | $324K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.1% | 771 | $304K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.0% | 2,051 | $291K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 5,605 | $278K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 2,054 | $269K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,034 | $268K |
| 81025 | <1% | 8,084 | $250K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,824 | $234K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,176 | $218K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,343 | $187K |
| 86850 | <1% | 2,800 | $176K | |
| 99285 | Emergency room visit (most serious) | <1% | 1,080 | $167K |
| 88141 | <1% | 6,756 | $167K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,551 | $165K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,734 | $161K |
| 88307 | <1% | 1,760 | $153K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,290 | $145K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 640 | $145K |
| 80050 | General health panel | <1% | 5,462 | $138K |
| 99051 | <1% | 3,996 | $131K | |
| 90686 | <1% | 5,347 | $120K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 912 | $117K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 673 | $115K |
| 99173 | <1% | 3,950 | $113K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 5,061 | $97K |
| 80061 | Lipid panel | <1% | 7,409 | $94K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,049 | $94K |
| 86900 | <1% | 2,796 | $86K | |
| 86481 | <1% | 2,114 | $84K | |
| 86901 | <1% | 2,797 | $82K | |
| 90651 | <1% | 982 | $81K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,012 | $76K |
| 88142 | <1% | 4,511 | $66K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,180 | $66K |
| 90715 | <1% | 1,972 | $63K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,028 | $63K |
| 90677 | <1% | 508 | $57K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 4,127 | $54K |
| 76801 | <1% | 378 | $52K | |
| 90670 | <1% | 2,029 | $44K | |
| S9485 | Crisis intervention mental health services, per diem | <1% | 35 | $44K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 143 | $40K |
| 83655 | <1% | 3,242 | $39K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 601 | $39K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,754 | $34K |
| 71045 | Radiologic examination, chest; single view | <1% | 6,249 | $32K |
| 0002A | <1% | 722 | $30K | |
| 90633 | <1% | 1,420 | $30K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 795 | $26K |
| 0001A | <1% | 718 | $25K | |
| 76830 | Ultrasound, transvaginal | <1% | 580 | $24K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,426 | $23K |
| 90680 | <1% | 1,155 | $23K | |
| G0378 | Hospital observation service, per hour | <1% | 486 | $20K |
| 90707 | <1% | 614 | $19K | |
| 86769 | <1% | 529 | $18K | |
| 90716 | <1% | 600 | $18K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,706 | $17K |
| 85610 | <1% | 4,916 | $17K | |
| 90697 | <1% | 707 | $17K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,882 | $15K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,962 | $15K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,232 | $14K |
| 76820 | <1% | 279 | $12K | |
| 90656 | <1% | 471 | $11K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 65 | $11K |
| 90698 | <1% | 580 | $10K | |
| 90648 | <1% | 562 | $10K | |
| 70486 | <1% | 220 | $10K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 59 | $10K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 68 | $9K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 336 | $8K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 27 | $8K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 210 | $8K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 129 | $7K |
| 80076 | <1% | 527 | $7K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 141 | $7K |
| 76818 | <1% | 58 | $7K | |
| 90723 | <1% | 360 | $6K | |
| 83880 | <1% | 235 | $6K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 397 | $6K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,982 | $6K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,672 | $6K |
| 0003A | <1% | 112 | $5K | |
| 83021 | <1% | 511 | $5K | |
| 90734 | <1% | 248 | $5K | |
| 90710 | <1% | 223 | $5K | |
| 0071A | <1% | 103 | $5K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,675 | $4K |
| 90744 | <1% | 241 | $4K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 15,982 | $4K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 951 | $4K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 5,422 | $4K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 46 | $4K |
| 90674 | <1% | 141 | $4K | |
| 90696 | <1% | 179 | $4K | |
| 87631 | <1% | 56 | $4K | |
| 0072A | <1% | 77 | $4K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 1,688 | $3K |
| 88304 | <1% | 247 | $3K | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,612 | $3K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,686 | $3K |
| 90700 | <1% | 161 | $3K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 134 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,831 | $3K |
| 73562 | <1% | 806 | $3K | |
| 73630 | <1% | 429 | $2K | |
| 88312 | <1% | 64 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 911 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,873 | $2K |
| 84702 | <1% | 2,295 | $2K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 844 | $2K |
| 96367 | <1% | 123 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,792 | $2K |
| 99385 | <1% | 14 | $2K | |
| 93017 | <1% | 12 | $1K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 38 | $1K |
| 90681 | <1% | 74 | $1K | |
| 0054A | <1% | 29 | $1K | |
| 97802 | <1% | 113 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 60 | $1K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 919 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,202 | $1K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 359 | $1K |
| 84439 | <1% | 2,165 | $1K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 23 | $1K |
| 73610 | <1% | 473 | $955.87 | |
| 82607 | <1% | 666 | $872.98 | |
| 95117 | <1% | 24 | $849.60 | |
| 85027 | <1% | 4,112 | $753.12 | |
| 73030 | <1% | 314 | $708.14 | |
| 86077 | <1% | 14 | $703.57 | |
| 76813 | <1% | 13 | $702.13 | |
| 82570 | <1% | 937 | $673.58 | |
| 86762 | <1% | 959 | $653.95 | |
| 72100 | <1% | 102 | $650.86 | |
| 82728 | <1% | 846 | $640.39 | |
| 86780 | <1% | 4,691 | $605.92 | |
| 86803 | <1% | 1,934 | $564.86 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 66 | $548.80 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 23 | $497.67 |
| 87088 | <1% | 3,919 | $488.93 | |
| 85730 | <1% | 5,042 | $468.79 | |
| 90647 | <1% | 26 | $464.10 | |
| 81001 | <1% | 8,564 | $463.31 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 427 | $460.03 |
| 73130 | <1% | 464 | $436.34 | |
| 90619 | <1% | 16 | $401.60 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 64 | $393.65 |
| 90688 | <1% | 14 | $388.22 | |
| 86003 | <1% | 211 | $378.37 | |
| 85007 | <1% | 3,643 | $372.05 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 210 | $369.35 |
| 83735 | <1% | 1,612 | $366.87 | |
| 86765 | <1% | 272 | $364.93 | |
| 87340 | <1% | 2,048 | $345.50 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 41 | $342.94 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 307 | $331.63 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 301 | $295.78 |
| 73080 | <1% | 26 | $294.27 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,084 | $287.88 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 162 | $274.98 |
| 72170 | <1% | 13 | $268.10 | |
| 73110 | <1% | 302 | $267.60 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 803 | $258.64 |
| 82043 | <1% | 578 | $249.13 | |
| 81003 | <1% | 6,114 | $247.85 | |
| 86580 | <1% | 31 | $216.32 | |
| J1815 | Injection, insulin, per 5 units | <1% | 89 | $211.66 |
| 73552 | <1% | 12 | $196.18 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 233 | $186.27 |
| 83540 | <1% | 493 | $184.53 | |
| 84100 | <1% | 999 | $170.36 | |
| 82947 | <1% | 4,993 | $157.86 | |
| 86706 | <1% | 278 | $155.42 | |
| 83550 | <1% | 339 | $143.21 | |
| 86787 | <1% | 310 | $115.92 | |
| 84153 | <1% | 91 | $114.02 | |
| 73140 | <1% | 70 | $98.09 | |
| 74018 | <1% | 12 | $98.09 | |
| 84481 | <1% | 287 | $97.44 | |
| 82746 | <1% | 139 | $88.20 | |
| 88300 | <1% | 13 | $61.33 | |
| 87070 | <1% | 724 | $60.02 | |
| 86735 | <1% | 44 | $56.55 | |
| 87077 | <1% | 514 | $35.68 | |
| 84703 | <1% | 416 | $33.67 | |
| 83605 | <1% | 1,829 | $32.47 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 74 | $32.42 |
| 86140 | <1% | 499 | $31.08 | |
| 73590 | <1% | 92 | $30.64 | |
| 82465 | <1% | 253 | $30.45 | |
| 85651 | <1% | 337 | $29.89 | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | <1% | 17 | $29.76 |
| 80164 | <1% | 44 | $27.08 | |
| 82150 | <1% | 261 | $25.92 | |
| 83690 | <1% | 3,078 | $24.04 | |
| 82950 | <1% | 264 | $23.75 | |
| 82270 | <1% | 14 | $21.90 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 15 | $21.30 |
| 82550 | <1% | 1,332 | $19.92 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 129 | $15.16 |
| 87186 | <1% | 317 | $13.53 | |
| 86704 | <1% | 45 | $12.05 | |
| 80320 | <1% | 2,573 | $10.75 | |
| 81002 | <1% | 87 | $10.54 | |
| 97803 | 0% | 50 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 676 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 276 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 160 | $0.00 |
| 82010 | 0% | 52 | $0.00 | |
| 82247 | 0% | 22 | $0.00 | |
| 87081 | 0% | 90 | $0.00 | |
| 96376 | 0% | 58 | $0.00 | |
| 94761 | 0% | 4,355 | $0.00 | |
| 87040 | 0% | 346 | $0.00 | |
| 73090 | 0% | 57 | $0.00 | |
| 82553 | 0% | 170 | $0.00 | |
| 84484 | 0% | 4,309 | $0.00 | |
| 94760 | 0% | 5,151 | $0.00 | |
| 81514 | 0% | 453 | $0.00 | |
| 85379 | 0% | 56 | $0.00 | |
| 85018 | 0% | 37 | $0.00 | |
| 86695 | 0% | 19 | $0.00 | |
| 86592 | 0% | 36 | $0.00 | |
| 97010 | 0% | 156 | $0.00 | |
| 36416 | 0% | 17 | $0.00 | |
| 80178 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDOSS, MOUNIR (CFO)
| Provider | Location | Paid |
|---|---|---|
| Jamaica Hospital | Richmond Hill, NY | $178.14M |
| Flushing Hospital & Medical Center | Flushing, NY | $52.79M |
| Jamaica Hospital | Jamaica, NY | $37.88M |
| Flushing Hospital & Medical Center | Flushing, NY | $18.18M |
| Advanced Center for Psychotherapy, INC. | Jamaica, NY | $15.08M |
| Jamaica Hospital Medical Center | Jamaica, NY | $1.42M |
| Medisys Ambulance Service INC | Jamaica, NY | $1.38M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.